Your browser doesn't support javascript.
loading
Electroacupuncture Pretreatment Prevents Cognitive Impairment Induced by Cerebral Ischemia-Reperfusion via Adenosine A1 Receptors in Rats.
Shi, Yiyi; Dai, Qinxue; Ji, Binbin; Huang, Luping; Zhuang, Xiuxiu; Mo, Yunchang; Wang, Junlu.
Afiliação
  • Shi Y; Department of Anesthesiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Dai Q; Department of Anesthesiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Ji B; Department of Anesthesiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Huang L; Department of Anesthesiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Zhuang X; Department of Anesthesiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Mo Y; Department of Anesthesiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Wang J; Department of Anesthesiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Front Aging Neurosci ; 13: 680706, 2021.
Article em En | MEDLINE | ID: mdl-34413765
ABSTRACT
A previous study has demonstrated that pretreatment with electroacupuncture (EA) induces rapid tolerance to focal cerebral ischemia. In the present study, we investigated whether adenosine receptor 1 (A1 R) is involved in EA pretreatment-induced cognitive impairment after focal cerebral ischemia in rats. Two hours after EA pretreatment, focal cerebral ischemia was induced by middle cerebral artery occlusion for 120 min in male Sprague-Dawley rats. The neurobehavioral score, cognitive function [as determined by the Morris water maze (MWM) test], neuronal number, and the Bax/Bcl-2 ratio was evaluated at 24 h after reperfusion in the presence or absence of CCPA (a selective A1 receptor agonist), DPCPX (a selective A1 receptor antagonist) into left lateral ventricle, or A1 short interfering RNA into the hippocampus area. The expression of the A1 receptor in the hippocampus was also investigated. The result showed that EA pretreatment upregulated the neuronal expression of the A1 receptor in the rat hippocampus at 90 min. And EA pretreatment reversed cognitive impairment, improved neurological outcome, and inhibited apoptosis at 24 h after reperfusion. Pretreatment with CCPA could imitate the beneficial effects of EA pretreatment. But the EA pretreatment effects were abolished by DPCPX. Furthermore, A1 receptor protein was reduced by A1 short interfering RNA which attenuated EA pretreatment-induced cognitive impairment.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Aging Neurosci Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Aging Neurosci Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China